Related Experiment Video
Updated: Jun 29, 2025

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
An Open-Source R Package for Detection of Adverse Events Under-Reporting in Clinical Trials: Implementation and
Björn Koneswarakantha1, Ronojit Adyanthaya2, Jennifer Emerson3
1F. Hoffmann-La Roche AG, 4070, Basel, Switzerland.
An open-source R package, simaerep, effectively detects adverse event (AE) under-reporting in clinical trials. This tool enhances data integrity and patient safety by providing rapid, comprehensive, and near-real-time site-level AE reporting analysis.
Area of Science:
- Clinical Trials Methodology
- Pharmacovigilance
- Data Science in Healthcare
Background:
- Accurate adverse event (AE) reporting is vital for clinical trial integrity and patient safety.
- AE under-reporting persists as a significant challenge, frequently identified during Good Clinical Practice (GCP) audits.
- Current methods like manual source data verification (SDV) have limitations in detecting AE under-reporting efficiently.
Purpose of the Study:
- To introduce and validate the open-source R package, simaerep, for detecting AE under-reporting.
- To assess the package's capability for rapid, comprehensive, and near-real-time AE under-reporting detection at the site level.
- To evaluate simaerep's performance against traditional methods and heuristic approaches.
Main Methods:
- Development of the open-source R package, simaerep, utilizing patient-level AE and visit data.
- Independent validation of the simaerep package by three member companies of the IntercoMPany quALity Analytics (IMPALA) consortium.
- Comparative analysis of simaerep's detection rates against heuristic methods.
Main Results:
- simaerep consistently and effectively identified AE under-reporting across all three validating companies.
- The package demonstrated superior detection rates compared to heuristic methods.
- simaerep identified 50% of all detectable sites by the 25% mark of the study duration.
Conclusions:
- The simaerep R package provides a robust solution for identifying AE under-reporting in clinical trials.
- Its integration into audits facilitates fast, holistic, and repeatable quality oversight.
- The tool significantly improves the ability to ensure data integrity and patient safety through timely AE detection.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Related Concept Videos
Statistical Software for Data Analysis and Clinical Trials
Steps in Outbreak Investigation
Kaplan-Meier Approach